Literature DB >> 30890538

Energy metabolism in cachexia.

Maria Rohm1,2, Anja Zeigerer1,2, Juliano Machado1,2, Stephan Herzig3,2,4.   

Abstract

Cachexia is a wasting disorder that accompanies many chronic diseases including cancer and results from an imbalance of energy requirements and energy uptake. In cancer cachexia, tumor-secreted factors and/or tumor-host interactions cause this imbalance, leading to loss of adipose tissue and skeletal and cardiac muscle, which weakens the body. In this review, we discuss how energy enters the body and is utilized by the different organs, including the gut, liver, adipose tissue, and muscle, and how these organs contribute to the energy wasting observed in cachexia. We also discuss futile cycles both between the organs and within the cells, which are often used to fine-tune energy supply under physiologic conditions. Ultimately, understanding the complex interplay of pathologic energy-wasting circuits in cachexia can bring us closer to identifying effective treatment strategies for this devastating wasting disease.
© 2019 The Authors.

Entities:  

Keywords:  adipose tissue; cachexia; inflammation; liver; skeletal muscle

Mesh:

Year:  2019        PMID: 30890538      PMCID: PMC6446208          DOI: 10.15252/embr.201847258

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  139 in total

1.  Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner.

Authors:  Pippa F Cosper; Leslie A Leinwand
Journal:  Cancer Res       Date:  2010-12-16       Impact factor: 12.701

2.  Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.

Authors:  C Drott; H Persson; K Lundholm
Journal:  Clin Physiol       Date:  1989-10

3.  Gastro-intestinal protein loss in elderly patients with cardiac cachexia.

Authors:  D King; M L Smith; M Lye
Journal:  Age Ageing       Date:  1996-05       Impact factor: 10.668

4.  Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects.

Authors:  S D Zuijdgeest-van Leeuwen; J W van den Berg; J L Wattimena; A van der Gaast; G R Swart; J H Wilson; P C Dagnelie
Journal:  Metabolism       Date:  2000-07       Impact factor: 8.694

5.  Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase.

Authors:  Lionel A Tintignac; Julie Lagirand; Sabrina Batonnet; Valentina Sirri; Marie Pierre Leibovitch; Serge A Leibovitch
Journal:  J Biol Chem       Date:  2004-11-05       Impact factor: 5.157

6.  White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma.

Authors:  Andrea Frontini; Alessandra Vitali; Jessica Perugini; Incoronata Murano; Chiara Romiti; Daniel Ricquier; Mario Guerrieri; Saverio Cinti
Journal:  Biochim Biophys Acta       Date:  2013-02-20

Review 7.  Mechanisms of cancer cachexia.

Authors:  Michael J Tisdale
Journal:  Physiol Rev       Date:  2009-04       Impact factor: 37.312

8.  Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin.

Authors:  Chih-Yen Chen; Chang-Youh Tsai; Pui-Ching Lee; Shou-Dong Lee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Role of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factor.

Authors:  S T Russell; K Hirai; M J Tisdale
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

10.  New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.

Authors:  Neil Johns; Cynthia Stretch; Benjamin H L Tan; Tora S Solheim; Sveinung Sørhaug; Nathan A Stephens; Ioannis Gioulbasanis; Richard J E Skipworth; D A Christopher Deans; Antonio Vigano; James A Ross; Oliver F Bathe; Michel L Tremblay; Stein Kaasa; Florian Strasser; Bruno Gagnon; Vickie E Baracos; Sambasivarao Damaraju; Kenneth C H Fearon
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-08-05       Impact factor: 12.910

View more
  40 in total

1.  MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.

Authors:  Sarah M Judge; Michael R Deyhle; Daria Neyroud; Rachel L Nosacka; Andrew C D'Lugos; Miles E Cameron; Ravneet S Vohra; Ashley J Smuder; Brandon M Roberts; Chandler S Callaway; Patrick W Underwood; Stephen M Chrzanowski; Abhinandan Batra; Meghan E Murphy; Jonathan D Heaven; Glenn A Walter; Jose G Trevino; Andrew R Judge
Journal:  Cancer Res       Date:  2020-03-04       Impact factor: 12.701

Review 2.  The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia.

Authors:  Mit Joshi; Bhoomika M Patel
Journal:  Mol Cell Biochem       Date:  2022-03-07       Impact factor: 3.396

3.  Editorial: Metabolic Adaptation of Muscle Tissue in Diseases Associated With Cachexia.

Authors:  Federica Cirillo; Teresa A Zimmers; Laura Mangiavini
Journal:  Front Cell Dev Biol       Date:  2022-06-03

4.  Primary Tumor Fluorine-18 Fluorodeoxydglucose (18F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival.

Authors:  Santiago Olaechea; Bhavani S Gannavarapu; Christian Alvarez; Anne Gilmore; Brandon Sarver; Donglu Xie; Rodney Infante; Puneeth Iyengar
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 5.  The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia.

Authors:  Ruijiang Zeng; Chang Tong; Xiangyang Xiong
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

Review 6.  Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.

Authors:  Jawed A Siddiqui; Ramesh Pothuraju; Maneesh Jain; Surinder K Batra; Mohd W Nasser
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-03-25       Impact factor: 10.680

Review 7.  Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison.

Authors:  Tamhida Masi; Bhoomika M Patel
Journal:  Pharmacol Rep       Date:  2020-11-03       Impact factor: 3.024

Review 8.  Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics.

Authors:  Pauline Morigny; Jeremie Boucher; Peter Arner; Dominique Langin
Journal:  Nat Rev Endocrinol       Date:  2021-02-24       Impact factor: 43.330

Review 9.  Body composition in patients with rheumatoid arthritis: a narrative literature review.

Authors:  Jean-Guillaume Letarouilly; René-Marc Flipo; Bernard Cortet; Anne Tournadre; Julien Paccou
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-21       Impact factor: 5.346

Review 10.  Molecular and Neural Mechanism of Dysphagia Due to Cancer.

Authors:  Ikuko Okuni; Yuta Otsubo; Satoru Ebihara
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.